Safety of Dueling NSCLC With Dual Agent Immunotherapy

Affiliations

• ¹ Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, Parkville, Australia; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ² Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia. Electronic address: [email protected].